{"id":41799,"date":"2025-09-18T15:30:09","date_gmt":"2025-09-18T07:30:09","guid":{"rendered":"https:\/\/flcube.com\/?p=41799"},"modified":"2025-09-18T15:30:09","modified_gmt":"2025-09-18T07:30:09","slug":"biocytogen-eyes-a%e2%80%91share-listing-on-shanghais-star-market-to-fund-preclinical-rd-growth","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=41799","title":{"rendered":"Biocytogen Eyes A\u2011Share Listing on Shanghai\u2019s STAR Market to Fund Preclinical R&amp;D Growth"},"content":{"rendered":"\n<p><strong>Biocytogen Pharmaceuticals (Beijing) Co., Ltd.<\/strong> (<a href=\"https:\/\/www.google.com\/finance\/quote\/2315:HKG\">HKG: 2315<\/a>) has filed a prospectus announcing plans to seek a listing on the <strong>Science and Technology Innovation Board (STAR Market)<\/strong> of the <strong>Shanghai Stock Exchange<\/strong>. The move follows the company\u2019s 2022 H\u2011share IPO on the Hong Kong Stock Exchange and aims to raise <strong>RMB\u202f1.185\u202fbillion<\/strong> in A\u2011share capital to accelerate its core contract\u2011research\u2011organization (CRO) activities.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-company-overview\">Company Overview<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Innovative pre\u2011clinical CRO<\/strong> specializing in <strong>antibody discovery<\/strong>, <strong>pre\u2011clinical pharmacology &amp; pharmacodynamics<\/strong>, and <strong>biotech development<\/strong> for pharma innovators.<\/li>\n\n\n\n<li>Proprietary <strong>RenMice platform<\/strong> for antibody screening and development.<\/li>\n\n\n\n<li>Delivered <strong>net losses<\/strong> of RMB\u202f663\u202fmillion (2022), RMB\u202f405\u202fmillion (2023), but achieved a <strong>turnover to a net profit of RMB\u202f23\u202fmillion<\/strong> in 2024, signaling operational stabilization.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-rationale-for-star-market-listing\">Rationale for STAR Market Listing<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Capital infusion<\/strong> will support expansion of core technologies and <strong>pipeline projects<\/strong> tied to the RenMice platform.<\/li>\n\n\n\n<li><strong>STAR Market\u2019s focus on high\u2011tech and biotech<\/strong> aligns with Biocytogen\u2019s innovation\u2011driven model, potentially enhancing valuation and investor visibility.<\/li>\n\n\n\n<li>The listing complements the company\u2019s existing Hong Kong presence, offering a <strong>dual\u2011market strategy<\/strong> to attract both domestic and international capital.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-financial-outlook\">Financial Outlook<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>A\u2011share offering<\/strong>: RMB\u202f1,185\u202fmillion (\u2248\u202fUS$170\u202fmillion).<\/li>\n\n\n\n<li>Proceeds earmarked for <strong>core business expansion<\/strong>, <strong>technology upgrades<\/strong>, and <strong>scaling of CRO services<\/strong>.<\/li>\n\n\n\n<li>Management projects that the capital raise will <strong>strengthen the balance sheet<\/strong> and support <strong>future R&amp;D initiatives<\/strong>.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-market-implications\">Market Implications<\/h2>\n\n\n\n<p>China\u2019s biotech and CRO sectors have attracted significant foreign investment, with the STAR Market serving as a launchpad for high\u2011growth companies. Biocytogen\u2019s listing could <strong>position it as a leading pre\u2011clinical CRO<\/strong> in the region, potentially generating new partnerships with global pharma firms seeking advanced antibody development platforms.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n\n\n\n<div data-wp-interactive=\"core\/file\" class=\"wp-block-file\"><object data-wp-bind--hidden=\"!state.hasPdfPreview\" hidden class=\"wp-block-file__embed\" data=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/2025091701194_c.pdf\" type=\"application\/pdf\" style=\"width:100%;height:600px\" aria-label=\"Embed of 2025091701194_c.\"><\/object><a id=\"wp-block-file--media-9ffa09bf-8698-4001-b5ae-f93b52cbadc1\" href=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/2025091701194_c.pdf\">2025091701194_c<\/a><a href=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/2025091701194_c.pdf\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-9ffa09bf-8698-4001-b5ae-f93b52cbadc1\">Download<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (HKG: 2315) has filed a prospectus announcing plans to seek&#8230;<\/p>\n","protected":false},"author":1,"featured_media":41800,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[1519,19,1214,72],"class_list":["post-41799","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-biocytogen-pharmaceuticals","tag-cro-cmo-cdmo","tag-hkg-2315","tag-ipo"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.4) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Biocytogen Eyes A\u2011Share Listing on Shanghai\u2019s STAR Market to Fund Preclinical R&amp;D Growth - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (HKG: 2315) has filed a prospectus announcing plans to seek a listing on the Science and Technology Innovation Board (STAR Market) of the Shanghai Stock Exchange. The move follows the company\u2019s 2022 H\u2011share IPO on the Hong Kong Stock Exchange and aims to raise RMB\u202f1.185\u202fbillion in A\u2011share capital to accelerate its core contract\u2011research\u2011organization (CRO) activities.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=41799\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Biocytogen Eyes A\u2011Share Listing on Shanghai\u2019s STAR Market to Fund Preclinical R&amp;D Growth\" \/>\n<meta property=\"og:description\" content=\"Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (HKG: 2315) has filed a prospectus announcing plans to seek a listing on the Science and Technology Innovation Board (STAR Market) of the Shanghai Stock Exchange. The move follows the company\u2019s 2022 H\u2011share IPO on the Hong Kong Stock Exchange and aims to raise RMB\u202f1.185\u202fbillion in A\u2011share capital to accelerate its core contract\u2011research\u2011organization (CRO) activities.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=41799\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-18T07:30:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/1807.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41799#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41799\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Biocytogen Eyes A\u2011Share Listing on Shanghai\u2019s STAR Market to Fund Preclinical R&amp;D Growth\",\"datePublished\":\"2025-09-18T07:30:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41799\"},\"wordCount\":297,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41799#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/1807.webp\",\"keywords\":[\"Biocytogen Pharmaceuticals\",\"CRO \\\/ CMO \\\/ CDMO\",\"HKG: 2315\",\"IPO\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=41799#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41799\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=41799\",\"name\":\"Biocytogen Eyes A\u2011Share Listing on Shanghai\u2019s STAR Market to Fund Preclinical R&amp;D Growth - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41799#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41799#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/1807.webp\",\"datePublished\":\"2025-09-18T07:30:09+00:00\",\"description\":\"Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (HKG: 2315) has filed a prospectus announcing plans to seek a listing on the Science and Technology Innovation Board (STAR Market) of the Shanghai Stock Exchange. The move follows the company\u2019s 2022 H\u2011share IPO on the Hong Kong Stock Exchange and aims to raise RMB\u202f1.185\u202fbillion in A\u2011share capital to accelerate its core contract\u2011research\u2011organization (CRO) activities.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41799#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=41799\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41799#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/1807.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/1807.webp\",\"width\":1080,\"height\":608,\"caption\":\"Biocytogen Eyes A\u2011Share Listing on Shanghai\u2019s STAR Market to Fund Preclinical R&D Growth\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41799#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Biocytogen Eyes A\u2011Share Listing on Shanghai\u2019s STAR Market to Fund Preclinical R&amp;D Growth\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Biocytogen Eyes A\u2011Share Listing on Shanghai\u2019s STAR Market to Fund Preclinical R&amp;D Growth - Insight, China&#039;s Pharmaceutical Industry","description":"Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (HKG: 2315) has filed a prospectus announcing plans to seek a listing on the Science and Technology Innovation Board (STAR Market) of the Shanghai Stock Exchange. The move follows the company\u2019s 2022 H\u2011share IPO on the Hong Kong Stock Exchange and aims to raise RMB\u202f1.185\u202fbillion in A\u2011share capital to accelerate its core contract\u2011research\u2011organization (CRO) activities.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=41799","og_locale":"en_US","og_type":"article","og_title":"Biocytogen Eyes A\u2011Share Listing on Shanghai\u2019s STAR Market to Fund Preclinical R&amp;D Growth","og_description":"Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (HKG: 2315) has filed a prospectus announcing plans to seek a listing on the Science and Technology Innovation Board (STAR Market) of the Shanghai Stock Exchange. The move follows the company\u2019s 2022 H\u2011share IPO on the Hong Kong Stock Exchange and aims to raise RMB\u202f1.185\u202fbillion in A\u2011share capital to accelerate its core contract\u2011research\u2011organization (CRO) activities.","og_url":"https:\/\/flcube.com\/?p=41799","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-09-18T07:30:09+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/1807.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=41799#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=41799"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Biocytogen Eyes A\u2011Share Listing on Shanghai\u2019s STAR Market to Fund Preclinical R&amp;D Growth","datePublished":"2025-09-18T07:30:09+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=41799"},"wordCount":297,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=41799#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/1807.webp","keywords":["Biocytogen Pharmaceuticals","CRO \/ CMO \/ CDMO","HKG: 2315","IPO"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=41799#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=41799","url":"https:\/\/flcube.com\/?p=41799","name":"Biocytogen Eyes A\u2011Share Listing on Shanghai\u2019s STAR Market to Fund Preclinical R&amp;D Growth - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=41799#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=41799#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/1807.webp","datePublished":"2025-09-18T07:30:09+00:00","description":"Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (HKG: 2315) has filed a prospectus announcing plans to seek a listing on the Science and Technology Innovation Board (STAR Market) of the Shanghai Stock Exchange. The move follows the company\u2019s 2022 H\u2011share IPO on the Hong Kong Stock Exchange and aims to raise RMB\u202f1.185\u202fbillion in A\u2011share capital to accelerate its core contract\u2011research\u2011organization (CRO) activities.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=41799#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=41799"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=41799#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/1807.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/1807.webp","width":1080,"height":608,"caption":"Biocytogen Eyes A\u2011Share Listing on Shanghai\u2019s STAR Market to Fund Preclinical R&D Growth"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=41799#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Biocytogen Eyes A\u2011Share Listing on Shanghai\u2019s STAR Market to Fund Preclinical R&amp;D Growth"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/1807.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/41799","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=41799"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/41799\/revisions"}],"predecessor-version":[{"id":41802,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/41799\/revisions\/41802"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/41800"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=41799"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=41799"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=41799"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}